Otomagnetics

Otomagnetics LLC, a spin-out from the University of Maryland College Park, was founded with the mission to revolutionize drug delivery methods for challenging areas such as the inner and middle ear, the eye, and the skin. The company's core vision is to provide non-invasive therapeutic solutions that overcome the limitations posed by biological barriers like the blood-labyrinth barrier in the inner ear. Otomagnetics offers a proprietary magnetic injection system designed to deliver drugs and other therapeutic payloads effectively and safely to these hard-to-reach areas.

Notable affiliated individuals include researchers and experts from the University of Maryland. The company has attracted significant interest from investors focused on innovative medical technologies. Key achievements include successful demonstrations of their magnetic injection system's efficacy in preclinical trials. Otomagnetics' impact lies in its potential to transform treatment protocols for inner ear diseases and other conditions requiring precise drug delivery, offering a less invasive and more effective alternative to current methods.